Search
for
Sort by
Community 30 of 420
- Hair Regrowth Following a Wnt- and Follistatin- Containing Treatment: Safety and Efficacy in a First-in-Man Phase 1 Clinical Trial: Scientific, Peer-Reviewed Dermatology Article Indexed with MEDLINE/PubMed
- Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says
- Verteporfin Phase 1 Human Clinical Trial In The Works
- Pyrilutamide phase III clinical trial results released
- Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy
- Verteporfin Phase 1 Human Clinical Trial In The Works - Research
- Pyrilutamide cleared for phase 3 clinical trial in china
- Han Bio Aims for Phase 1 Clinical Trials in 2027 after successful hair growth in mice
- Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- US FDA will now default to only one clinical trial for drug applications, will this accelerate the release of PP405 and other drugs in clinical trials?
- Amplifica and AMP-303 clinical phase 1
- Brief update clascoterone phase 3 - Breezula
- GT20029 phase II results release date?
- Pp405 phase 2a clinical results
- When do we hear about Pelage February 2025 study results?
- The story of RU58841/ PSK3841
- Kintor stealing pictures from a hair transplant clinic to promote their failed product (KX826, Pyrilutamide)
- Clascoterone study going on right now
- Koshinemall is official site, confirmed
- Can RU58841 stop hairloss for a long time?
- Why do I have the feeling that this subreddit is flooded by Kintor employees?
- GT20029 - Promising phase II results
- Where is GT20029 already? Grrrr
- Today was Last update on pp405
- How promising is kintor pyrilutamide?
- PP405 2a study was a safety study. Some rational explaining.
- Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?
- Phase 3 Study for PP405 officially posted